KZA 0.00% 8.0¢ kazia therapeutics limited

ASX, page-94

  1. 20,376 Posts.
    lightbulb Created with Sketch. 1808
    This is my last response to you Explacy, I am putting you on ignore, I should have done it well before this knowing full well what they say about arguing with a fool.

    "The document on the Novogen website is May 2015=WRONG!"

    Try this and look at the date on the bottom of the page-:

    http://www.novogen.com/pdf/Jacob_Hope.pdf

    see this at the bottom of that page May 2016
    Why in the hell would Novogen update their website with this information if it is wrong?

    Jacob Hope drug discovery projects

    Facioscapulohumeral muscular dystrophy (FSHD)
     Focal brain injury
     Lysosomal storage disorders


    Facioscapulohumeral Dystrophy (FSHD)
    FSHD is a progressive disease of skeletal muscle that has no cure. Novogen used human embryonic stem cells carrying the FSHD genetic mutation to screen for compounds that reverse markers of the disease process in cell culture. Two compounds from this screen met the desired screening criteria and advanced to the next stage of validation involving a detailed analysis of the biochemistry that underpins their effect. This project is funded by the Australian not-for-profit organisation FSHD Global.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.